Celmatix

About:

Celmatix is a preclinical-stage biotech transforming women's lives through better ovarian health.

Twitter/X: celmatix

Top Investors: GLG, Evotec, Advanced Research Projects Agency for Health, Topspin Partners, Richmond Global Ventures

Description:

Celmatix is a next-generation women’s health company. They focus on reproductive health and fertility. Through their platform, they have amassed the largest structured dataset on ovarian health and outcomes in the world.

Total Funding Amount:

$57.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)celmatix.com.

Founders:

Laura Towart, Piraye Yurttas Beim

Number of Employees:

101-250

Last Funding Date:

2024-10-23

IPO Status:

Private

Industries: